CLINICAL_TRIALS
trial_result
· 2017-04-17
Clinical Trial Update: Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma [Phase 2]
Summary
Phase 2 study evaluating amrubicin as first-line chemotherapy for metastatic or unresectable soft tissue sarcoma; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Utah | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2017-04-17